Skip to content

Evaluation of the intestinal environment for pregnant women and infants

Evaluation of the intestinal environment for pregnant women and infants - Evaluation of the intestinal environment for pregnant women and infants

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000043094
Enrollment
30
Registered
2021-01-22
Start date
2021-01-22
Completion date
Unknown
Last updated
2026-09-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy pregnant women

Interventions

None listed

Sponsors

Metabologenomics, Inc.
Lead Sponsor
Nihonkai General Hospital
Collaborator

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) Healthy pregnant women aged more than or equal to 20 and less than 40 years old. (2) Subjects who show understanding of the study procedures and agreement with participating the study by written informed consent prior to the study.

Exclusion criteria

Exclusion criteria: (1) Subjects who are currently receiving medication. (2) Subjects who are diagnosed with gestational diabetes or gestational hypertension. (3) Subjects who have consumed medicines which affect the intestinal environment within the last 1 month to the observation start. (4) Subjects who have current medical history/anamnesis of severe cardiac, hepatic, renal or digestive diseases. (5) Subjects who are heavy use of alcohol. (6) Smokers. (7) Subjects who have extremely irregular dietary habits,working hours or daily rhythms. (8) Subjects who are currently participating, or who have participated in other study for medicine or food within the last 4 weeks of the present study, or who possibly participate in another clinical trial after agreement of this study. (9) Subjects who have been determined ineligible by principal investigator or sub-investigator.

Design outcomes

Primary

MeasureTime frame
Intestinal microbiome and intestinal metabolome

Secondary

MeasureTime frame
Child atopy and eczema incidence rate (48 weeks old)

Countries

Japan

Contacts

Public ContactYumiko Ichimura

Nihonkai General Hospital Medical support department

clinical-trials@metagen.co.jp+81234262001

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Sep 19, 2026